◼ Archived
Business
🔮 holds ✓
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is expanding into endocrinology with a record-breaking $10 billion acquisition of biotech specialist Crinetics.